Business Context and Reporting Period
This Form 8-K filing by Becton, Dickinson and Company (BD) covers the event date of March 24, 2014. The report addresses corporate governance changes specifically regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial performance data.
Material Changes
The primary material change reported is the election of Claire Pomeroy to the Board of Directors on March 24, 2014. She was appointed to the Corporate Governance and Nominating Committee and the Science, Marketing, Innovation and Technology Committee. The Board determined Dr. Pomeroy is independent under NYSE rules and BD's Corporate Governance Principles.
Guidance, Outlook, and Compensation
There is no guidance, outlook, or management commentary regarding future financial performance in this filing. Regarding compensation, Dr. Pomeroy received a grant of 1,299 restricted stock units as part of her appointment. This grant is prorated from the effective date of her election through the 2015 Annual Meeting of Shareholders. Full details on non-management director compensation are referenced in the company's 2014 proxy statement.
Investor Verification Points
- Verify Dr. Pomeroy's independence status and committee assignments in the company's latest proxy statement.
- Confirm the vesting schedule and terms of the 1,299 restricted stock units granted.
- Review the 2014 Annual Meeting proxy statement for the complete "Non-Management Directors' Compensation" table.